Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. - Wikidata - awgldk - TriplyDB

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.

http://www.wikidata.org/entity/Q44653206

about

Focal therapy in prostate cancer: the current situation Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.Long-term functional outcomes after treatment for localized prostate cancer.Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer.Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis Clinical management and burden of prostate cancer: a Markov Monte Carlo model.Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT.Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost.Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes Late gastrointestinal toxicities following radiation therapy for prostate cancer.Management of high-risk localized prostate cancer.Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan(®) instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis Radioresistance of prostate cancer cells with low proteasome activity.Extracting the Benefit of Nexrutine® for Cancer Prevention.Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group.Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach.Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.Antitumor effects of (32)P-chromic-poly (L-lactide) brachytherapy in nude mice with human prostate cancer Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last?CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients.Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report.Outcomes of high-dose intensity-modulated radiotherapy alone with 1 cm planning target volume posterior margin for localized prostate cancer.Current and emerging treatments in the management of castration-resistant prostate cancer.Re-irradiation for salvage of prostate cancer failures after primary radiotherapy.Clinical controversies: proton therapy for prostate cancer.African American prostate cancer survivorship: Exploring the role of social support in quality of life after radical prostatectomy.Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer.Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer.

P2860

Q28242346-F7C5093B-0AC0-4FCC-8FF3-6D1FD02F0071 Q30151845-4C3D2466-BDBE-4D93-9544-7864EE4EC662 Q30376901-591E947D-CED0-486A-B73D-84B41EA47ADF Q30542816-600991D5-5726-4D4F-B3FB-40CC373580DF Q33651525-AF8BB83B-9038-44F8-8DA6-107EF381A213 Q33679365-8B4B4D45-1FA0-44E5-8E36-B3BF6A0866D7 Q34413524-F6DEE6A7-F9C2-4C6B-8CB7-9238B08DACBF Q34500966-7B4E3021-4458-47D9-86A0-CA1DF4201685 Q34634410-1E856812-E29A-46F7-8115-436A8ED0A2E5 Q34810730-E304FCDA-1C98-4C30-89A1-8DC7895F1865 Q35085833-B727C55C-9A4A-4B0B-877F-B9FD825D4135 Q35111988-4EFBBAAC-2F9B-4763-83D6-EFD8AD6B5F14 Q35212795-EBC7891F-6733-4A89-96C2-868B35D0AA90 Q35256076-69366220-C245-4A4D-8FAE-F783D6C33AB5 Q35503645-48DFD64F-343E-4DD2-853F-3F78C75109B2 Q35515150-68BC712C-AE6F-43AD-BAD8-DDBA3F4BEE3A Q35835126-A3303610-E4B0-4B36-9EA2-E5A6B8A59B50 Q35901614-5795F1CF-1F4B-4232-BD77-BEE6D442EC80 Q36094487-D57879E7-FA1D-4864-A834-E9D788B5CD72 Q36236997-58C56EFC-D9CE-4EF3-8123-95ECFC519F50 Q36384072-56510074-4BBC-4835-8C84-9E917A080446 Q36500061-53052287-A8A9-4F2B-B760-C305606B7889 Q36609888-11F7C4E8-575F-48DD-AADB-CB71E690D173 Q36921562-8DB38E7F-641B-486A-B5ED-8923E547E39D Q37139334-6EB5FCF0-CC42-4A6B-BBDB-702F2CBAB1B7 Q37195789-7765F9E1-BA6B-4162-85D2-0EC61FE24D62 Q37211798-02138607-3C24-483D-B4C3-81BD19E5494C Q37284915-4B368776-D036-44A5-8361-B7988883CD2F Q37289333-0DEEBEDC-2D2F-4DB5-9F57-6D315D0887E5 Q37549491-9E090EA9-D112-475A-938F-F1D3192C7466 Q37717598-201D778E-6DF4-41A3-997A-E8D9E76B8C2C Q38030595-55902371-0B58-4E99-B519-C3E88A5EE426 Q38051008-4F60AC96-8191-48DA-9F98-BF2C5C2B5E04 Q38087711-4A07F3E7-0355-4BB2-86D3-119592A387C5 Q38557906-EC546212-49BA-43BE-87EF-559E8419D3D9 Q38640272-E8FEE548-51C9-4152-96B5-4B91157C0362 Q39088175-84EF3BE6-5711-411B-A1AD-86A54A14BDE2 Q39197792-5CF98D30-B13C-4115-B5C6-9390D5A675E6 Q39593619-511CC380-6BE4-4A0C-8E3F-23CE4A3FA69C Q39701289-A05EDBE1-8EF0-4294-95C6-76AECFAD31CC

P2860

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.

http://www.wikidata.org/entity/Q44653206

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@en

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@nl

type

label

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@en

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@nl

prefLabel

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@en

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@nl

P1433

Q44653206-28F13AE1-2849-416C-89BD-9D353768D4E6

P1476

Q44653206-1F5489D8-8ABC-469F-BBD3-0ADF5419DC5E

P2093

Q44653206-097CF8B0-1217-4E05-93E7-D71084A394B0

Q44653206-2FB0010F-6034-4283-B443-F82A492768FE

Q44653206-43A3B32D-3E53-4AC1-82D3-E920EC3BD568

Q44653206-65265ECB-32C4-4E43-8BDC-5132466433EB

Q44653206-8B894004-51F4-45E8-97AA-E6802952EEA8

Q44653206-AE96AF7A-28D1-4655-BDF2-21643C5D304E

P2860

Q44653206-02B41A51-89B2-44AD-A476-67632747CABF

Q44653206-09646662-086D-4406-A6E3-DC218CF09217

Q44653206-1564B05D-11A4-4343-B09D-5C6A93A8249E

Q44653206-1D7497B2-076C-49EF-AFE4-7B63B0713DD0

Q44653206-2724D2D7-3010-4472-8982-97C161928B05

Q44653206-2BE4BEAB-6530-4C2B-8ED3-045E7B0744E0

Q44653206-31288DD6-6B77-4B31-84F1-AE80682D3AF7

Q44653206-44D942D3-31D0-4FD5-8C2C-E1226A305BF9

Q44653206-47614668-F18E-4DE5-8D2F-815BFB4CB162

Q44653206-76659E89-8ECA-4F99-A0FB-615E657A97CB

P304

Q44653206-AAB232B2-A790-41FC-B47E-A02391A2C47E

P31

Q44653206-FB27211B-1483-4F3E-9641-97437F481AE3

P356

Q44653206-8A5E3CC7-F3F6-491A-AB75-882F17B78A01

P407

Q44653206-B0E851F3-4A2D-41CC-B1CD-F1418B1FE5BD

P433

Q44653206-B90DF416-0013-4587-9148-B58E7E3EF9A5

P478

Q44653206-AB862E6A-45EC-454F-AC86-0A484F433962

P50

Q44653206-A0CE55B8-95A3-4301-9764-3D7B61A76130

Q44653206-A4289AC7-2AF5-46BC-8DF9-9CF82C495AA2

P577

Q44653206-FD4603E0-22B5-4D5C-8AE3-791FCABE69EC

P5875

Q44653206-5CF7CC29-A420-42B7-85BF-9D8EFAFB7D6B

P698

Q44653206-0E6190E4-81F9-4226-B085-A9D6FD2A60A6

P921

Q44653206-532CB3C9-F54E-478C-8AB8-DB67CAFDEB6D

P356

P1433

P1476

Ten-year outcomes of high-dose ...... for localized prostate cancer.

@en

P2093

Brett Cox

http://www.w3.org/2001/XMLSchema#string

Marisa Kollmeier

http://www.w3.org/2001/XMLSchema#string

Xin Pei

http://www.w3.org/2001/XMLSchema#string

Yoshiya Yamada

http://www.w3.org/2001/XMLSchema#string

Zhigang Zhang

http://www.w3.org/2001/XMLSchema#string

Zumre A Alicikus

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Radiation dose and late failures in prostate cancer.

Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy.

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.

The potential and limitations of the inverse radiotherapy technique.

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

P304

1429-1437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25467

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Zelefsky

P577

2010-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50598530

http://www.w3.org/2001/XMLSchema#string

P698

21425143

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy